Newer Therapies in Dermatophytosis

Author:

Poddar Shreya,Das Anupam,Hay Roderick James,Wollina Uwe

Abstract

With the advent of newer drugs and formulations, the armamentarium to combat dermatophytosis is ever-expanding. However, we must be rational and scientific when choosing the drugs. This review is an attempt to summarise the recently approved and upcoming therapeutic options for dermatophytosis.

Publisher

Medknow

Reference29 articles.

1. The emergence of Trichophyton indotineae: Implications for clinical practice;Gupta;Int J Dermatol,2023

2. Current insights on antifungal therapy: Novel nanotechnology approaches for drug delivery systems and new drugs from natural sources;Sousa;Pharmaceuticals (Basel,2020

3. Ciclopirox hydroxypropyl chitosan (HPCH) nail lacquer: A review of its use in onychomycosis;Piraccini;Dermatol Ther (Heidelb,2020

4. An innovative terbinafine transungual solution [p-3058]: Dose finding investigation on clinical benefit in patients affected by mild-to-moderate toe onychomycosis;Iorizzo;J Am Acad Dermatol,2013

5. Activity of TDT 067 (terbinafine in Transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations;Ghannoum;J Clin Microbiol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3